BUSINESS VERTICALS
Domestic Formulations
Domestic formulation business of RPG Life Sciences manufactures and markets branded finished dosage formulations in India.
The business has major presence in over 10 therapeutic areas including Nephrology, Oncology, Urology, Respiratory, Vitamins & Minerals, Gastro Intestinal, Pain Management, Cardio-vascular, etc.
The product portfolio of the company includes some of the well-known textbook brands such as Aldactone, Serenace, Naprosyn, Azoran, Lomotil and Lomofen+.
Orion Division
Orion Division focuses primarily on chronic and specialty therapies Cardiovascular, Diabetology, Urology. Orion's portfolio reflects a strategic focus on long term therapy management, specialty care, and high-involvement prescriber segments.
PINNACLE Division
PINNACLE Division houses RPG Life Sciences iconic legacy brands and strong mass-prescription portfolios. The division caters to high reach therapies including: Orthopedics,Gastrointestinal,Respiratory / Allergy,Nutritional and other general medicines. Pinnacle continues to drive volume leadership, strong brand recall, and wide prescriber coverage, backed by several brands with over five decades of presence in Indian pharma.
Integra Division
For over two decades, the Integra division at RPG Life Sciences has been in the management of Chronic Kidney Diseases, kidney transplant, high end infections and dialysis.
The Division has some landmark brands that has revolutionized the therapy in the Chronic Kidney Disease management. It is proud to have the patent brand of Cyclosporine in micro- emulsion technology - ARPIMUNE ME. The division has also been a pioneer to launch AZORAN (Azathioprine), indigenously developed and manufactured in India, thus making the product available to Indian masses not depending on imported brands.
The in-house R&D team has also developed for the first time in India - The Only Indigenously developed Medicinal Ketoanalogue - ALFALOG which is approved by the DCGI as medicinal grade ketoanalogue.
Today, as per ORG- IMS Nephrocare division of RPG Life Sciences Ltd has been ranked as No. 1 company among the players in this therapeutic area.
In the recent past, the division has expanded its wings in the area of critical care. The objective is to further make inroads in the area of Nephrology through the support of Critical care. Several high end injectables have been introduced for high end infection management. Nephrocare now caters to highly specialised transplant, dialysis and high end infection management drugs to restore the essence of life.
Neolife Division
Neolife division at RPG Life Sciences was launched in July 2010 with a product mix of chemotherapy, supportive care and palliative care.
The division has been in line with its motto of launching advanced formulations with enhanced efficacy and safety. It launched NabPac, a nano particle bound paclitaxel, which has several advantages compared to its predecessor.
The division is looking forward to expand it biological and biosimilar portfolio. It launched a biosimilar, HerMab, which is used in the treatment of breast cancer.
Neolife division is in the process of launching few more advanced formulations by the way of in-licensing and co-development.